Imaging features of adrenal masses D Albano, F Agnello, F Midiri, G Pecoraro, A Bruno, P Alongi, P Toia, ... Insights into imaging 10, 1-16, 2019 | 107 | 2019 |
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT P Alongi, M Picchio, F Zattoni, M Spallino, L Gianolli, G Saladini, ... European journal of nuclear medicine and molecular imaging 43, 464-473, 2016 | 85 | 2016 |
18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis E Incerti, E Tombetti, F Fallanca, EM Baldissera, P Alongi, E Tombolini, ... European journal of nuclear medicine and molecular imaging 44, 1109-1118, 2017 | 67 | 2017 |
A cross-validation of FDG-and amyloid-PET biomarkers in mild cognitive impairment for the risk prediction to dementia due to Alzheimer’s disease in a clinical setting L Iaccarino, K Chiotis, P Alongi, O Almkvist, A Wall, C Cerami, V Bettinardi, ... Journal of Alzheimer's Disease 59 (2), 603-614, 2017 | 66 | 2017 |
Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: An explorative study on machine learning feature classification in … P Alongi, A Stefano, A Comelli, R Laudicella, S Scalisi, G Arnone, ... European Radiology 31, 4595-4605, 2021 | 59 | 2021 |
18F-Fluoroethylcholine (18F-Cho) PET/MRI Functional Parameters in Pediatric Astrocytic Brain Tumors. BJB Fraioli F, Shankar A, Hargrave D, Hyare H, Gaze MN, Groves AM, Alongi P ... Clinical Nuclear Medicine, 2014 | 56* | 2014 |
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study F Caobelli, P Alongi, L Evangelista, M Picchio, G Saladini, M Rensi, ... European journal of nuclear medicine and molecular imaging 43, 404-413, 2016 | 51 | 2016 |
Evaluation of an optimized [18F]fluoro‐deoxy‐glucose positron emission tomography voxel‐wise method to early support differential diagnosis in atypical … SP Caminiti, P Alongi, L Majno, MA Volontč, C Cerami, L Gianolli, G Comi, ... European Journal of Neurology 24 (5), 687-e26, 2017 | 45 | 2017 |
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT P Alongi, F Caobelli, R Gentile, A Stefano, G Russo, D Albano, S Baldari, ... European journal of nuclear medicine and molecular imaging 44, 224-233, 2017 | 44 | 2017 |
Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization … F Fallanca, P Alongi, E Incerti, L Gianolli, M Picchio, I Kayani, J Bomanji European journal of nuclear medicine and molecular imaging 43, 1837-1848, 2016 | 43 | 2016 |
Inflammatory pseudotumor of mediastinum treated with tomotherapy and monitored with FDG-PET/CT: case report and literature review F Alongi, A Bolognesi, AMS Gajate, M Motta, C Landoni, G Berardi, ... Tumori Journal 96 (2), 322-326, 2010 | 42 | 2010 |
Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies-a multicenter experience. A Cistaro, P Coppolino, N Quartuccio, C Altini, M Cucinotta, P Alongi, ... Hellenic journal of nuclear medicine 18 (2), 97-102, 2015 | 41 | 2015 |
18F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis R Laudicella, D Albano, P Alongi, G Argiroffi, M Bauckneht, S Baldari, ... Cancers 11 (9), 1348, 2019 | 39 | 2019 |
Somatostatin receptor PET/CT imaging for the detection and staging of pancreatic NET: a systematic review and meta-analysis M Bauckneht, D Albano, S Annunziata, G Santo, P Guglielmo, ... Diagnostics 10 (8), 598, 2020 | 38 | 2020 |
Radiation treatment of lymph node recurrence from prostate cancer: is 11C-choline PET/CT predictive of survival outcomes? E Incerti, A Fodor, P Mapelli, C Fiorino, P Alongi, M Kirienko, ... Journal of Nuclear Medicine 56 (12), 1836-1842, 2015 | 36 | 2015 |
Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis L Agnello, T Piccoli, M Vidali, L Cuffaro, B Lo Sasso, G Iacolino, VR Giglio, ... Scandinavian Journal of Clinical and Laboratory Investigation 80 (4), 313-317, 2020 | 35 | 2020 |
Neuropsychological and FDG-PET profiles in VGKC autoimmune limbic encephalitis A Dodich, C Cerami, S Iannaccone, A Marcone, P Alongi, C Crespi, ... Brain and Cognition 108, 81-87, 2016 | 35 | 2016 |
The role of PET/CT in the evaluation of patients affected by limbic encephalitis: A systematic review of the literature N Quartuccio, F Caobelli, L Evangelista, P Alongi, M Kirienko, V De Biasi, ... Journal of Neuroimmunology 284, 44-48, 2015 | 32 | 2015 |
Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A … B De Bari, R Mazzola, D Aiello, S Fersino, F Gregucci, P Alongi, ... La radiologia medica 123, 719-725, 2018 | 27 | 2018 |
[68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept R Laudicella, A Comelli, V Liberini, A Vento, A Stefano, A Spataro, ... Cancers 14 (4), 984, 2022 | 24 | 2022 |